Sources: Apple working with US researchers to offer DNA testing via ResearchKit
Apple Has Plans for Your DNA — The iPhone could become a new tool in genetic studies. — Of all the rumors ever to swirl around the world's most valuable company, this may be the first that could involve spitting in a plastic cup.
Context & Ripple Effects
Apple launched ResearchKit in March 2015 as a framework letting medical researchers run studies through the iPhone, and follow-up coverage showed it was built specifically to strip out the friction of enrolling participants. Two months later, the company is reportedly extending that same pipeline from self-reported data to biological samples: DNA testing offered to U.S. researchers through ResearchKit itself.
The move slots into a longer arc visible across the coverage — by 2017 Apple was reportedly working with Health Gorilla to pull blood work and hospital lab results onto the iPhone, and separately in talks with the Argonaut Project and Carin Alliance to make the device a shareable medical-records hub. Genomics would be the most personal layer yet.
First-order effects
- Academic researchers get a recruitment and sample-collection channel at population scale — the enrollment bottleneck that ResearchKit was designed to remove now applies to genetic studies, not just surveys and sensor data.
- iPhone owners who opt in become direct contributors to research studies, shifting DNA collection out of clinics and dedicated testing services and into the phone's existing health stack.
Second-order effects
- Pharmaceutical R&D becomes a plausible customer: GlaxoSmithKline and Purdue Pharma were already evaluating ResearchKit for drug development two months later, and genomic cohorts tied to consented iPhone users would make that proposition considerably more valuable.
- The push pressures the broader health-data ecosystem Apple was assembling — the Health Gorilla lab-data integration and the records-hub talks give genetic results a place to live alongside blood work, raising the stakes for whichever partners control that plumbing.
Third-order effects
- If the pattern holds, the iPhone consolidates into a longitudinal health record spanning behavior, clinical labs, and genome — a structure that makes Apple a de facto intermediary between consumers, researchers, and drugmakers, with consent management as the core product feature.
- Consumer genomics migrates from standalone test kits toward platforms that already own the user relationship, forcing the question of how genetic data held on a mass-market consumer device is governed — a regulatory frontier the coverage implies but has not resolved.
The trend: Apple is methodically turning the iPhone from a fitness tracker into the default container for personal health data, with each integration — ResearchKit, labs, records, and now reportedly DNA — widening what the device holds.